Group 1 - The core viewpoint of the article highlights that Xinyi Medical achieved a turnaround in 2025, reporting a revenue exceeding 400 million yuan and setting a 2026 target of at least 540 million yuan in revenue and 100 million yuan in profit, indicating confidence in growth prospects [1] Group 2 - In the recent stock performance, Xinyi Medical's B-share price showed volatility over the past week, with a 5-day change of -0.57%, and the latest stock price at 48.50 HKD. The trading volume during this period was approximately 4.57 million HKD, with technical indicators suggesting short-term adjustment pressure [2]